From: Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
Patient | Anti-AQP4 | Clinical characteristics | Malignoma | Associated autoimmune disease | Duration of follow-up (years) |
---|---|---|---|---|---|
#1 | + | ON and LETM | - | Sjögren’s syndrome | 4 |
#2 | - | ON and LETM | - | - | 3 |
#3 | - | ON and LETM | - | Hashimoto’s thyroiditis | 6 |
#4 | + | LETM | - | - | 5,5 |
#5 | - | ON and LETM | Astrocytomaa | - | 10 |
#6 | + | LETM | - | - | 2 |
#7 | - | ON and LETM | - | - | 5 |
#8 | - | ON and LETM | - | Hashimoto’s thyroiditis | 5 |
#9 | - | ON and LETM | - | - | 5 |
#10 | - | ON and LETM | - | Hashimoto’s thyroiditis | 9 |
#11 | + | ON and LETM | - | - | 0.5 |
#12 | + | LETM | - | Systemic lupus erythematosus | 5 |
#13 | + | ON and LETM | - | - | 6 |
#14 | - | ON and LETM | - | - | 5.5 |
#15 | - | ON and LETM | AML | - | 6 |
#16 | + | ON and LETM | - | Sjögren’s syndrome | 1 |
#17 | - | ON and LETM | - | - | 2 |
#18 | + | ON and LETM | - | - | 8 |
#19 | + | ON and LETM | - | Non-differentiated collagenosis | 3.5 |
#20 | + | ON and LETM | - | - | 8 |
#21 | + | LETM | - | - | 0.5 |
#22 | + | LETM | - | Hashimoto's thyroiditis | 7 |
#23 | + | ON and LETM | - | - | 1 |